CAP-derived clinical material for Phase I-II studies is produced by our CDMO partners
- GenIbet in Lisbon/Portugal – CAP CDMO Joint Venture
- Paragon in Baltimore/Maryland – CEVEC’s preferred CDMO in North America
CEVEC assists in selecting the appropriate CDMO partner, with the final choice being made by our clients.
Based on our CAP Technology platform we perform
- cGMP Master and Working Cell Bank production
- cGMP bulk protein production
- Quality Control / Quality Assurance Services
- Fill and finish
- Support of dossier filing with Regulatory Authorities.
Benefit from our extensive know-how and expertise and contact us at: email@example.com